Contact: Sarah Seagraves, Senior VP for Marketing (405) 813-2403 or email sseagraves@i2E.org OKLAHOMA CITY — i2E, Inc., recently led an $889,000 investment round in Stillwater, OK-based MaxQ, a startup company that has developed proprietary insulated packaging systems for the blood supply chain and associated life science industries. MaxQ offers a comprehensive suite of validated, reusableRead more
News
Scott Meacham Copyright © 2017, The Oklahoma Publishing Company There’s always a lot of discussion around pros and cons of state-sponsored venture capital funds. A recent Kauffman Foundation white paper even postulates that states should avoid state VC funds. The suggestion is that state-sponsored funds don’t match private VC funds when it comes to returnRead more
Copyright © 2017, The Oklahoma Publishing Company Datebox Inc., an Oklahoma City startup company that provides couples with creative dating ideas and products, has secured a $2.6 million seed round investment. The investment round included $1.3 million from the i2E-managed Oklahoma Seed Capital Fund, along with $300,000 from the SeedStep Angels group, also managed byRead more
Oklahoma startups are cashing in By Jack Money Copyright © 2016, The Oklahoma Publishing Company Chalk up WeGoLook, LLC’s deal with Crawford & Co. as another success story for i2E and the Oklahoma Center for the Advancement of Science and Technology. On Dec. 6, Crawford & Co. announced it would acquire an 85 percent membershipRead more
Two major acquisitions of local firms good news in several ways By Scott Meacham Copyright © 2016, The Oklahoma Publishing Company I had an amazing Friday a couple of weeks ago. Literally, in one day, I found out that two of i2E’s portfolio companies were being acquired by major corporations — the two biggest exitsRead more
i2E Inc. recently led a $1.25 million seed round investment in Linear Health Sciences, a Norman-based innovative medical technology startup.
Ten years ago, Oklahoma’s landscape for seed capital was like Black Mesa. We were high and dry. There was no venture capital money here. SeedStep Angels hadn’t been organized yet. Entrepreneurs simply didn’t have access to the investment capital to fund the milestones that move young companies from concept to startup to potential successes in the marketplace.
Angel investors are called angels for a reason. These accredited investors are the primary source of early stage capital for startup firms. The metric for angel investing is return on investment; however, angels, who are often former entrepreneurs or retired business persons, also show a strong desire to help entrepreneurs.
i2E Inc. recently closed on a $249,000 follow-on investment in WeGoLook LLC.
i2E participates in $1.5 million financing round in WeGoLook with $249,000 follow-on investment Oklahoma City-based WeGoLook provides crowdsourced field inspection and verification services for individual and enterprise clients by dispatching an on-demand network of more than 20,000 “Lookers” to capture key information about assets or perform custom tasks via its web and mobile platform. Contact:Read more
From Staff Reports Copyright © 2015 The Oklahoma Publishing Co. i2E Inc. and Accele Venture Partners recently closed a $600,000 follow-on investment in Synereca Pharmaceuticals, a portfolio company of Accele Biopharma, an Oklahoma City-based biotechnology accelerator. With the most recent investment, Synereca has now received $2.5 million in funding to support its development of compoundsRead more
i2E and Accele Venture capital recently lead a $2.2 million investment in Pamilco Biopharma. i2E invested t through its Oklahoma Seed Capital Fund.
From The Oklahoman: i2E Inc. recently closed on a $1.75 million Series A equity investment in Oklahoma City-based WeGoLook LLC.
i2E, Inc., recently closed on a $1.75 million Series A equity investment in Oklahoma City-based WeGoLook, LLC, which provides onsite verification services through a national network of 15,000 field agents.
Synereca Pharmaceuticals has received $1.4 million in seed capital from i2E Inc. The Oklahoma City-based company is developing a compound that kills drug resistant bacteria.
i2E, Inc., recently closed on a $1.4 million seed capital investment in Oklahoma City-based Synereca Pharmaceuticals, which is developing ground-breaking compound that kills drug resistant bacteria.
i2E, Inc., recently closed on a $1.4 million Series A preferred equity investment in Tulsa-based Well Checked Systems International, LLC.
Oklahoma City-based Otologic Pharmaceutics Inc. has received $4.1 million to help fund a treatment for noise-induced hearing loss.
A pair of investment funds managed by i2E, Inc., recently closed a $1.2 million investment in Oklahoma City’s Otologic Pharmaceutics, Inc., a company developing novel treatments for hearing disorders.
The Seed Capital Fund, managed by i2E Inc., recently closed a $150,000 investment in Tulsa-based ReTenant, part of a $300,000 funding round that also included $25,000 from the i2E-managed SeedStep Angels and out of state investors.
